Hold-rated reports

904 tickers rated Hold
NewestHighest Score Ranks all reports in this rating group by score, highest first.
Sumitomo Mitsui Financial Group, Inc.
SMFG·Financials
B ★★★Hold
Current$24.74
Target$27.30
Return+10.3%
Nov 16, 2026

Sumitomo Mitsui benefits from Japan's interest-rate normalization, resilient banking relationships, and rising shareholder returns, but its elevated price-to-book valuation leaves limited room for disappointing profitability.

Score
67
NIQ Global Intelligence plc
NIQ·Technology
B ★★★Hold
Current$19.36
Target$21.75
Return+12.3%
Nov 15, 2026

NIQ's proprietary global consumer data, resilient subscriptions, and improving cash flow create a credible long-term growth opportunity, but leverage and demanding implied cash-flow growth limit the near-term margin of safety.

Score
67
Credicorp Ltd.
BAP·Financials
B ★★★Hold
Current$368.74
Target$402.00
Return+9.0%
Nov 12, 2026

Credicorp combines a highly profitable Peruvian banking franchise with growing digital monetization and attractive dividends, but elevated historical valuation multiples and weather-related credit risks constrain the margin of safety.

Score
67
TG Therapeutics, Inc.
TGTX·Healthcare
B ★★★Hold
Current$65.76
Target$70.00
Return+6.4%
Nov 12, 2026

TG Therapeutics is rapidly scaling a profitable multiple sclerosis franchise with significant pipeline optionality, but its premium valuation and dependence on BRIUMVI leave limited room for commercial or clinical disappointment.

Score
67
Take-Two Interactive Software, Inc.
TTWO·Communication Services
B ★★★Hold
Current$231.31
Target$259.79
Return+12.3%
Nov 12, 2026

Take-Two's unmatched gaming franchises and imminent GTA VI launch could drive a major earnings and cash-flow inflection, but elevated expectations, uneven current profitability, and blockbuster execution risk constrain valuation upside.

Score
67
Constellation Energy Corporation
CEG·Utilities
B ★★★Hold
Current$274.73
Target$300.00
Return+9.2%
Nov 12, 2026

Constellation Energy benefits from scarce nuclear assets and rising demand for reliable power, but its valuation premium, capital-intensive expansion, and Calpine-related leverage limit the margin of safety.

Score
67
Seaboard Corporation
SEB·Industrials
B ★★★Hold
Current$3,783.74
Target$4,489.63
Return+18.7%
Nov 10, 2026

Seaboard offers diversified hard assets and potential upside from a discount to book value, but weak free cash flow, commodity volatility and inconsistent operating returns limit the investment case.

Score
67
Main Street Capital Corporation
MAIN·Financials
B ★★★Hold
Current$57.01
Target$61.25
Return+7.4%
Nov 8, 2026

Main Street Capital offers durable monthly income, efficient private-credit operations, and equity-investment upside, but its substantial premium to NAV and slower distributable earnings growth constrain capital appreciation.

Score
67
Gildan Activewear Inc.
GIL·Consumer Discretionary
B ★★★Hold
Current$34.75
Target$45.10
Return+29.8%
Nov 8, 2026

Gildan's low-cost apparel manufacturing platform and HanesBrands synergies offer earnings recovery potential at a discounted valuation, but weak demand, elevated debt, and uncertain recurring cash flow constrain the upside case.

Score
67
TransMedics Group, Inc.
TMDX·Healthcare
B ★★★Hold
Current$88.24
Target$103.91
Return+17.8%
Nov 8, 2026

TransMedics combines differentiated organ-preservation technology with a scalable transplant logistics platform, offering substantial long-term growth potential, but weak cash conversion and operating-margin pressure constrain near-term upside.

Score
67